Type 1 innate lymphoid cells (ILC1) are tissue-resident lymphocytes that provide early protection against bacterial and viral infections. Discrete transcriptional states of ILC1 have been identified in homeostatic and pathological contexts. However, whether these states delineate ILC1 with different functional properties is not completely understood. Here, we show that liver ILC1 are heterogeneous for the expression of distinct effector molecules and surface receptors, including granzyme A (GzmA) and CD160, in mice. ILC1 expressing high levels of GzmA are enriched in the liver of adult mice, and represent the main hepatic ILC1 population at birth. However, the heterogeneity of GzmA and CD160 expression in hepatic ILC1 begins perinatally and increases with age. GzmA+ ILC1 differ from NK cells for the limited homeostatic requirements of JAK/STAT signals and the transcription factor Nfil3. Moreover, by employing Rorc(γt)-fate map (fm) reporter mice, we established that ILC3-ILC1 plasticity contributes to delineate the heterogeneity of liver ILC1, with RORγt-fm+ cells skewed toward a GzmA–CD160+ phenotype. Finally, we showed that ILC1 defined by the expression of GzmA and CD160 are characterized by graded cytotoxic potential and ability to produce IFN-γ. In conclusion, our findings help deconvoluting ILC1 heterogeneity and provide evidence for functional diversification of liver ILC1.

Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver / Di Censo, C.; Marotel, M.; Mattiola, I.; Muller, L.; Scarno, G.; Pietropaolo, G.; Peruzzi, G.; Laffranchi, M.; Mazej, J.; Hasim, M. S.; Asif, S.; Russo, E.; Tomaipitinca, L.; Stabile, H.; Lee, S. -H.; Vian, L.; Gadina, M.; Gismondi, A.; Shih, H. -Y.; Mikami, Y.; Capuano, C.; Bernardini, G.; Bonelli, M.; Sozzani, S.; Diefenbach, A.; Ardolino, M.; Santoni, A.; Sciume', G.. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - (2021). [10.1002/eji.202149209]

Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver

Di Censo C.
Primo
;
Scarno G.;Pietropaolo G.;Laffranchi M.;Mazej J.;Russo E.;Tomaipitinca L.;Stabile H.;Vian L.;Gismondi A.;Capuano C.;Bernardini G.;Sozzani S.;Ardolino M.;Santoni A.
;
Sciume' G.
Ultimo
2021

Abstract

Type 1 innate lymphoid cells (ILC1) are tissue-resident lymphocytes that provide early protection against bacterial and viral infections. Discrete transcriptional states of ILC1 have been identified in homeostatic and pathological contexts. However, whether these states delineate ILC1 with different functional properties is not completely understood. Here, we show that liver ILC1 are heterogeneous for the expression of distinct effector molecules and surface receptors, including granzyme A (GzmA) and CD160, in mice. ILC1 expressing high levels of GzmA are enriched in the liver of adult mice, and represent the main hepatic ILC1 population at birth. However, the heterogeneity of GzmA and CD160 expression in hepatic ILC1 begins perinatally and increases with age. GzmA+ ILC1 differ from NK cells for the limited homeostatic requirements of JAK/STAT signals and the transcription factor Nfil3. Moreover, by employing Rorc(γt)-fate map (fm) reporter mice, we established that ILC3-ILC1 plasticity contributes to delineate the heterogeneity of liver ILC1, with RORγt-fm+ cells skewed toward a GzmA–CD160+ phenotype. Finally, we showed that ILC1 defined by the expression of GzmA and CD160 are characterized by graded cytotoxic potential and ability to produce IFN-γ. In conclusion, our findings help deconvoluting ILC1 heterogeneity and provide evidence for functional diversification of liver ILC1.
2021
CD160; granzyme A; innate lymphoid cells; natural killer; Nfil3
01 Pubblicazione su rivista::01a Articolo in rivista
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver / Di Censo, C.; Marotel, M.; Mattiola, I.; Muller, L.; Scarno, G.; Pietropaolo, G.; Peruzzi, G.; Laffranchi, M.; Mazej, J.; Hasim, M. S.; Asif, S.; Russo, E.; Tomaipitinca, L.; Stabile, H.; Lee, S. -H.; Vian, L.; Gadina, M.; Gismondi, A.; Shih, H. -Y.; Mikami, Y.; Capuano, C.; Bernardini, G.; Bonelli, M.; Sozzani, S.; Diefenbach, A.; Ardolino, M.; Santoni, A.; Sciume', G.. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - (2021). [10.1002/eji.202149209]
File allegati a questo prodotto
File Dimensione Formato  
DiCenso_Granzyme-A_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.18 MB
Formato Adobe PDF
2.18 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1569445
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 23
social impact